Meeting
2023 ASCO Gastrointestinal Cancers Symposium
The Wnt signaling pathway in gastrointestinal cancers.
Authors
Zoran Gatalica
Exact Sciences Corp, Phoenix, AZ;
Zoran Gatalica , Turgut W Dogruluk , Pawan Noel , Susan M. Dombrowski , Lenny Hong , Michelle Barbi , Thiruppavai Chandrasekaran , Gargi D. Basu , David W. Hall , Jess R Hoag , Madappa N. Kundranda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 807)
DOI
10.1200/JCO.2023.41.4_suppl.807
Abstract #
807
Poster Bd #
N2
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Molecular landscape of colorectal cancers harboring R-spondin fusions.
First Author: Andreas Seeber
Poster
2024 ASCO Genitourinary Cancers Symposium
Canonical Wnt signaling pathway (WSP) alterations in metastatic prostate cancer.
First Author: Sharon Choi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).
First Author: Lesly Torres-Gonzalez
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The impact of Wnt pathway alterations including RNF43, GNAS, CTNNB1, and APC on prognosis and potential therapeutic vulnerability in pancreatic adenocarcinoma (PDAC).
First Author: Naoko Takebe